U.S. Markets open in 6 hrs 31 mins

Can the Uptrend Continue for AVEO Pharmaceuticals (AVEO)?

Zacks Equity Research

Investors certainly have to be happy with AVEO Pharmaceuticals, Inc. (AVEO) and its short term performance. After all, the stock has jumped by 47.7% in the past 4 weeks, and it is also above its 20 Day Simple Moving Average as well. This is certainly a good trend, but investors are probably asking themselves, can this positive trend continue for AVEO?

While we can never know for sure, it is pretty encouraging that estimates for AVEO have moved higher in the past few weeks, meaning that analyst sentiment is moving in the right way. Plus, the stock actually has a Zacks Rank #2 (Buy), so the recent move higher for this spotlighted company may definitely continue over the next few weeks.


Zacks Investment Research